Breast Cancer

Integrated minimally invasive and systemic options for breast oncology.

Cancer

Overview

The breast programme covers screening-detected lesions, invasive ductal and lobular carcinoma, ductal carcinoma in situ, and recurrent disease. Core biopsy with receptor testing (ER, PR, HER2, Ki-67) guides the entire plan.

Treatment pathways

Care may include surgery, image-guided ablation for selected small tumours, systemic therapy, and radiation planning. Fertility preservation and genetic counselling (BRCA1/2) are offered before treatment starts when relevant.

Recovery and support

Patients receive wound-care guidance, lymphoedema screening, and a structured survivorship schedule. A dedicated international-patient coordinator manages appointments so treatment is not delayed by travel logistics.

Still have questions?

Reach our care team for personalized guidance on diagnosis, treatment, and insurance.

Request a Consultation
← Back to Cancer